ARTICLE | Company News
Progenics other research news
December 13, 1993 8:00 AM UTC
Progenics received a $500,000 Phase II SBIR grant from the National Institute of Allergy and Infectious Diseases to develop its second-generation gp120 vaccine. In the first phase of its research prog...